198
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Pharmacoepigenomic Responses of Antipsychotic Drugs on Pharmacogenes are Likely to be Modulated by miRNAs

, , , &
Pages 811-821 | Received 22 Dec 2016, Accepted 21 Mar 2017, Published online: 21 Apr 2017

References

  • Ackenheil M , WeberK . Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects . Dialogues Clin. Neurosci.6 ( 1 ), 71 ( 2004 ).
  • Smith E , WestonCA , LiebermanA . Schizophrenia (maintenance treatment) . BMJ Clin. Evid. ( 2009 ). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907810/
  • Broekema W , De GrootI , Van HartenP . Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics – a European study . Pharm. World Sci.29 ( 3 ), 126 – 130 ( 2007 ).
  • Razzouk D , KayoM , SousaAet al. The impact of antipsychotic polytherapy costs in the public health care in Sao Paulo, Brazil . PLoS ONE10 ( 4 ), e0124791 ( 2015 ).
  • Chaplin R , McguiganS . Antipsychotic dose: from research to clinical practice . Psychiatrist20 ( 8 ), 452 – 454 ( 1996 ).
  • Harrington M , LelliottP , PatonC , OkochaC , DuffettR , SenskyT . The results of a multi-centre audit of the prescribing of antipsychotic drugs for in-patients in the UK . Psychiatrist26 ( 11 ), 414 – 418 ( 2002 ).
  • Jerrell JM , McintyreRS . Adverse events in children and adolescents treated with antipsychotic medications . Hum. Psychopharm.23 ( 4 ), 283 – 290 ( 2008 ).
  • Nielsen R , LolkA , ValentinJ , AndersenK . Cumulative dosages of antipsychotic drugs are associated with increased mortality rate in patients with Alzheimer’s dementia . Acta Psychiatr. Scand.134 ( 4 ), 314 – 320 ( 2016 ).
  • Malhotra AK , MurphyGMJr , KennedyJL . Pharmacogenetics of psychotropic drug response . Am. J. Psychiatry161 ( 5 ), 780 – 796 ( 2004 ).
  • Ventola CL . Role of pharmacogenomic biomarkers in predicting and improving drug response: part 1: the clinical significance of pharmacogenetic variants . P T38 ( 9 ), 545 ( 2013 ).
  • Ivanov M , KacevskaM , Ingelman-SundbergM . Epigenomics and interindividual differences in drug response . Clin. Pharmacol. Ther.92 ( 6 ), 727 – 736 ( 2012 ).
  • Ingelman-Sundberg M , ZhongXB , HankinsonOet al. Potential role of epigenetic mechanisms in the regulation of drug metabolism and transport . Drug Metab. Dispos.41 ( 10 ), 1725 – 1731 ( 2013 ).
  • Tang X , ChenS . Epigenetic regulation of cytochrome P450 enzymes and clinical implication . Curr. Drug Metab.16 ( 2 ), 86 – 96 ( 2015 ).
  • Reed K , ParissentiAM . Epigenetic regulation of ABCB1 transporter expression and function . Curr. Pharmacogenomics Pers. Med.8 ( 3 ), 218 – 231 ( 2010 ).
  • Vijayan NN , MathewA , BalanSet al. Antipsychotic drug dosage and therapeutic response in schizophrenia is influenced by ABCB1 genotypes: a study from a south Indian perspective . Pharmacogenomics13 ( 10 ), 1119 – 1127 ( 2012 ).
  • Saradalekshmi KR , NeethaNV , SathyanS , NairIV , NairCM , BanerjeeM . DNA methyl transferase (DNMT) gene polymorphisms could be a primary event in epigenetic susceptibility to schizophrenia . PLoS ONE9 ( 5 ), e98182 ( 2014 ).
  • Dweep H , StichtC , PandeyP , GretzN . miRWalk-database: prediction of possible miRNA binding sites by ‘walking’ the genes of three genomes . J. Biomed. Inform.44 ( 5 ), 839 – 47 ( 2011 ).
  • Gerets H , TilmantK , GerinBet al. Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins . Cell Biol. Toxicol.28 ( 2 ), 69 – 87 ( 2012 ).
  • Raeder MB , Fern⊘J , Vik-MoAO , SteenVM . SREBP activation by antipsychotic-and antidepressant-drugs in cultured human liver cells: relevance for metabolic side-effects?Mol. Cell. Biochem.289 ( 1–2 ), 167 – 173 ( 2006 ).
  • Bespalov A , MüllerR , ReloAL , HudzikT . Drug tolerance: a known unknown in translational neuroscience . Trends Pharmacol. Sci.37 ( 5 ), 364 – 378 ( 2016 ).
  • Alenius M , WadeliusM , DahlML , HartvigP , LindströmL , Hammarlund-UdenaesM . Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting . J. Psychiatr. Res.42 ( 11 ), 884 – 893 ( 2008 ).
  • Boulton DW , DevaneCL , ListonHL , MarkowitzJS . In vitro P-glycoprotein affinity for atypical and conventional antipsychotics . Life Sci.71 ( 2 ), 163 – 169 ( 2002 ).
  • Consoli G , LastellaM , CiapparelliAet al. ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients . Pharmacogenomics10 ( 8 ), 1267 – 1276 ( 2009 ).
  • Beveridge N , GardinerE , CarrollA , TooneyP , CairnsM . Schizophrenia is associated with an increase in cortical microRNA biogenesis . Mol. Psychiatry15 ( 12 ), 1176 – 1189 ( 2010 ).
  • Haduch A , WójcikowskiJ , DanielWA . Direct effects of neuroleptics on the activity of CYP2A in the liver of rats . Pharmacol. Rep.57 ( 6 ), 867 – 871 ( 2005 ).
  • Hanagama M , InoueH , KamiyaM , ShinoneK , NataM . Gene expression on liver toxicity induced by administration of haloperidol in rats with severe fatty liver . Leg. Med.10 ( 4 ), 177 – 184 ( 2008 ).
  • Kim IW , HanN , BurckartGJ , OhJM . Epigenetic changes in gene expression for drug-metabolizing enzymes and transporters . Pharmacotherapy34 ( 2 ), 140 – 150 ( 2014 ).
  • Rodriguez-Antona C , GomezA , KarlgrenM , SimSC , Ingelman-SundbergM . Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment . J. Hum. Genet.127 ( 1 ), 1 – 17 ( 2010 ).
  • Tsuchiya Y , NakajimaM , TakagiS , TaniyaT , YokoiT . MicroRNA regulates the expression of human cytochrome P450 1B1 . Cancer Res.66 ( 18 ), 9090 – 9098 ( 2006 ).
  • Pan YZ , GaoW , YuAM . MicroRNAs regulate CYP3A4 expression via direct and indirect targeting . Drug Metab. Dispos.37 ( 10 ), 2112 – 2117 ( 2009 ).
  • Perkins DO , JeffriesCD , JarskogLFet al. microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder . Genome Biol.8 ( 2 ), 1 ( 2007 ).
  • Santarelli DM , LiuB , DuncanCEet al. Gene–microRNA interactions associated with antipsychotic mechanisms and the metabolic side effects of olanzapine . Psychopharmacology227 ( 1 ), 67 – 78 ( 2013 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.